• TPCA-1: Precision IKK-2 Inhibitor for Inflammation Research

  2026-06-18

  TPCA-1 delivers targeted and highly selective inhibition of IKK-2, enabling robust NF-κB pathway modulation and cytokine suppression for advanced inflammation and rheumatoid arthritis research. Its reproducibility, quantifiable efficacy, and compatibility with complex disease models set it apart for translational workflows.

• Leucovorin Calcium in Tumor Microenvironment Modeling

  2026-06-18

  Explore how Leucovorin Calcium enhances research on folate metabolism and drug resistance in complex tumor microenvironments. This article reveals new assay strategies and translational insights distinct from existing reviews.

• Structure-Based Screening Identifies NSP15 Inhibitors for SA

  2026-06-17

  The reference study applies structure-based virtual screening to identify thymopentin and oleuropein as potent inhibitors of SARS-CoV-2 NSP15, an endoribonuclease implicated in immune evasion. These findings expand the repertoire of antiviral targets and suggest new strategies for host-directed COVID-19 interventions.

• DOT1L Inhibition Enhances Lenalidomide Efficacy in Myeloma M

  2026-06-17

  This study uncovers how DOT1L inhibition reprograms innate immunity and significantly potentiates the anti-myeloma effects of lenalidomide. By elucidating the epigenetic and immune mechanisms underlying this synergy, the findings offer actionable insights for optimizing immunomodulatory strategies in multiple myeloma research.

• UK-5099 (PF-1005023) in Immunometabolism Workflows

  2026-06-16

  UK-5099 (PF-1005023) empowers immunometabolic research by precisely targeting mitochondrial pyruvate transport, enabling researchers to dissect metabolic regulation of immune responses with high reproducibility. This guide translates protocol innovations and troubleshooting from recent studies into practical steps for optimizing cytokine profiling and metabolism-modulated whole-blood assays.

• Tofacitinib Restores Mitochondrial Function in RA Macrophage

  2026-06-16

  This study demonstrates that Tofacitinib (CP-690550) uniquely reverses both inflammatory signaling and mitochondrial dysfunction in GM-CSF-reprogrammed macrophages from rheumatoid arthritis (RA) patients. By targeting STAT5 signaling, Tofacitinib outperformed anti-TNF, anti-IL6R, and metabolic interventions, revealing new avenues for immune modulation in RA.

• Tin Mesoporphyrin IX (chloride): Precision Inhibition for HO

  2026-06-15

  Tin Mesoporphyrin IX (chloride) from APExBIO is a benchmark inhibitor for dissecting heme oxygenase function in metabolic and viral disease models. This article navigates optimized workflows, troubleshooting, and advanced cross-domain applications, translating recent peer-reviewed insights into actionable experimental strategies.

• Quercetin Protects Cataract Lenses via Hippo Pathway Modulat

  2026-06-15

  This study elucidates how quercetin alleviates cataract pathology by inhibiting the Hippo signaling pathway, leading to reduced lens opacity and enhanced epithelial survival in both in vivo and in vitro cataract models. The findings highlight Hippo pathway suppression as a major mechanism for quercetin's protective role, providing a molecular target for non-surgical cataract interventions.

• Mapping Mutational Drivers in Myeloma Cell Lines and Therapy

  2026-06-14

  This study delivers a comprehensive exome-wide analysis of 30 human multiple myeloma cell lines, uncovering recurrent mutations and altered signaling pathways that underlie tumor progression and resistance to therapy. These insights refine model selection for hematological malignancy research and inform experimental strategies for probing drug responses in genetically diverse myeloma.

• C34: Strategic TLR4 Inhibition for Translational Inflammatio

  2026-06-13

  This thought-leadership article explores the mechanistic and translational significance of TLR4-mediated inflammatory signaling, emphasizing the unique role of C34 (CAS 40592-88-9) as a selective TLR4 inhibitor. Integrating recent advances from neuroinflammation and aging models, the article guides researchers through experimental protocols and strategic considerations, highlighting C34's advantages for dissecting pathophysiological mechanisms in macrophages, enterocytes, and beyond.

• Imipramine in Translational Research: Autophagy, Apoptosis,

  2026-06-12

  This article examines the expanding utility of Imipramine, a tricyclic antidepressant, as a research tool in autophagy and apoptosis studies. By integrating mechanistic insights from lipidomics and viral-host interactions, we provide strategic guidance for translational researchers exploring oncology, neuroprotection, and immunomodulation.

• Rucaparib (AG-014699): Protocols for DNA Repair and Radiosen

  2026-06-12

  Rucaparib (AG-014699) is redefining DNA repair and radiosensitization research by enabling precise, reproducible studies in models ranging from prostate cancer to hepatocellular carcinoma. This guide delivers actionable workflows, troubleshooting insights, and a direct bridge to cutting-edge findings about spliceosome regulation and PARP inhibitor synergy.

• HyperScribe All in One mRNA Synthesis Kit Plus 1: Workflow &

  2026-06-11

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 empowers rapid, high-yield synthesis of ARCA-capped, immune-evasive mRNA for advanced applications such as RNA vaccine development and in vitro translation. Its streamlined, modification-rich workflow is validated by recent breakthroughs in mRNA vaccine research, offering researchers a reliable bridge from bench to translational impact.

• EZ Cap™ Human PTEN mRNA: Redefining Tumor Suppressor Gene mR

  2026-06-11

  Explore how EZ Cap™ Human PTEN mRNA advances tumor suppressor gene mRNA research with next-generation cap structure, stability, and translational efficiency—revealing how molecular features translate to practical gains in cancer research, gene therapy, and mRNA delivery innovation.

• Leucovorin Calcium in Tumor Microenvironment Modeling: Advan

  2026-06-10

  Explore how Leucovorin Calcium empowers cutting-edge research on the tumor microenvironment and drug resistance in gastric cancer. This article delivers unique insights into calcium folinate's mechanistic role and practical assay optimization—bridging molecular detail with translational impact.

16268 records 1/1085 page Next 12345 下5页 Last page